(VIANEWS) – Good morning! Another day of trading is almost starting and here’s today’s list of stocks that have had significant trading activity in the US premarket session.
The three biggest winners today are Banco Bradesco, Banco Bradesco, and Nano Dimension.
| Rank | Financial Asset | Price | Premarket Change |
Updated (EST) |
|---|---|---|---|---|
| 1 | Banco Bradesco (BBD) | 3.76 | 3.01% | 2023-06-22 04:38:17 |
| 2 | Banco Bradesco (BBD) | 3.76 | 3.01% | 2023-06-22 04:38:17 |
| 3 | Nano Dimension (NNDM) | 2.35 | 0.79% | 2023-06-22 07:15:19 |
| 4 | CSX Corporation (CSX) | 33.37 | 0.72% | 2023-06-22 04:36:44 |
| 5 | Southwestern Energy (SWN) | 5.51 | 0.36% | 2023-06-22 04:45:09 |
| 6 | Vanguard Total International Bond (BNDX) | 48.86 | 0.18% | 2023-06-22 07:23:14 |
| 7 | NRG Energy (NRG) | 33.90 | 0.06% | 2023-06-22 04:43:16 |
| 8 | Coca-Cola (KO) | 61.43 | 0% | 2023-06-22 04:42:07 |
| 9 | SK Telecom (SKM) | 20.08 | 0% | 2023-06-22 04:20:45 |
| 10 | Smith & Wesson (SWBI) | 11.70 | 0% | 2023-06-22 04:15:14 |
The three biggest losers today are Gyrodyne, Inovio Pharmaceuticals, and GlaxoSmithKline.
| Rank | Financial Asset | Price | Premarket Change |
Updated (EST) |
|---|---|---|---|---|
| 1 | Gyrodyne (GYRO) | 11.00 | -5.9% | 2023-06-22 07:10:21 |
| 2 | Inovio Pharmaceuticals (INO) | 0.47 | -2.25% | 2023-06-22 07:25:37 |
| 3 | GlaxoSmithKline (GSK) | 34.59 | -1.59% | 2023-06-22 04:41:06 |
| 4 | Smith & Nephew (SNN) | 31.11 | -0.7% | 2023-06-22 07:21:42 |
| 5 | Fresenius Medical Care AG (FMS) | 23.55 | -0.42% | 2023-06-22 04:33:35 |
| 6 | Petroleo Brasileiro (PBR) | 14.92 | -0.13% | 2023-06-22 04:43:41 |
| 7 | Ares Capital (ARCC) | 18.58 | -0.05% | 2023-06-22 07:22:55 |
| 8 | Wipro Limited (WIT) | 4.62 | 0% | 2023-06-22 04:46:27 |
| 9 | Smith & Wesson (SWBI) | 11.70 | 0% | 2023-06-22 04:15:14 |
| 10 | Coca-Cola (KO) | 61.43 | 0% | 2023-06-22 04:42:07 |
Premarket Winners today
1. Banco Bradesco (BBD) – Premarket: 3.01%
Banco Bradesco S.A., together with its subsidiaries, provides various banking products and services to individuals, corporates, and businesses in Brazil and internationally. The company operates through two segments, Banking and Insurance. It provides current, savings, click, and salary accounts; real estate credit, vehicle financing, payroll loans, mortgage loans, microcredit, leasing, and personal and installment credit; debit and business cards; financial and security services; consortium products; auto, personal accident, dental, travel, and life insurance; investment products; pension products; real estate and vehicle auctions; cash management, and foreign trade and exchange services; capitalization bonds; and internet banking services. Banco Bradesco S.A. was founded in 1943 and is headquartered in Osasco, Brazil.
NYSE ended the session with Banco Bradesco jumping 0.83% to $3.65 on Thursday while NYSE jumped 0.05% to $15,657.00.
Earnings Per Share
As for profitability, Banco Bradesco has a trailing twelve months EPS of $0.34.
PE Ratio
Banco Bradesco has a trailing twelve months price to earnings ratio of 10.74. Meaning, the purchaser of the share is investing $10.74 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.82%.
Sales Growth
Banco Bradesco’s sales growth is negative 41.7% for the current quarter and 4.7% for the next.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Banco Bradesco’s stock is considered to be oversold (<=20).
Volatility
Banco Bradesco’s last week, last month’s, and last quarter’s current intraday variation average was 1.23%, 0.65%, and 1.83%.
Banco Bradesco’s highest amplitude of average volatility was 1.41% (last week), 1.67% (last month), and 1.83% (last quarter).
Volume
Today’s last reported volume for Banco Bradesco is 5293080 which is 79.76% below its average volume of 26160800.
More news about Banco Bradesco.
2. Banco Bradesco (BBD) – Premarket: 3.01%
Banco Bradesco S.A., together with its subsidiaries, provides various banking products and services to individuals, corporates, and businesses in Brazil and internationally. The company operates through two segments, Banking and Insurance. It provides current, savings, click, and salary accounts; real estate credit, vehicle financing, payroll loans, mortgage loans, microcredit, leasing, and personal and installment credit; debit and business cards; financial and security services; consortium products; auto, personal accident, dental, travel, and life insurance; investment products; pension products; real estate and vehicle auctions; cash management, and foreign trade and exchange services; capitalization bonds; and internet banking services. Banco Bradesco S.A. was founded in 1943 and is headquartered in Osasco, Brazil.
NYSE ended the session with Banco Bradesco jumping 0.83% to $3.65 on Thursday, after two consecutive sessions in a row of gains. NYSE rose 0.05% to $15,657.00, following the last session’s upward trend on what was a somewhat up trend trading session today.
Earnings Per Share
As for profitability, Banco Bradesco has a trailing twelve months EPS of $0.34.
PE Ratio
Banco Bradesco has a trailing twelve months price to earnings ratio of 10.74. Meaning, the purchaser of the share is investing $10.74 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.82%.
Yearly Top and Bottom Value
Banco Bradesco’s stock is valued at $3.65 at 08:34 EST, way under its 52-week high of $4.16 and way above its 52-week low of $2.34.
Growth Estimates Quarters
The company’s growth estimates for the present quarter is a negative 30.8% and positive 11.1% for the next.
More news about Banco Bradesco.
3. Nano Dimension (NNDM) – Premarket: 0.79%
Nano Dimension Ltd., together with its subsidiaries, provides additive electronics in Israel and internationally. The company offers 3D printers, comprising DragonFly IV that produces Hi-PEDs by depositing proprietary conductive and dielectric substances, as well as integrates in-situ capacitors, antennas, coils, transformers, and electromechanical components; digital light processing printers (DLP) that achieves production-grade polymer and composite parts; and admaflex that utilizes a patented DLP foil system that fabricates ceramic and metal parts. It also provides additive electronics robotics and control systems, which includes surface-mount-technology, an electronics assembly equipment for electronic components on Hi-PEDs and PCBs, catering to various manufacturing and volume requirements; and ink delivery systems controls electronics, software, and ink delivery systems for digital printing. In addition, the company offers software to provide engineers with the tools to bring precision and electrical parts from design-to-manufacturing, as well as sells various materials that are developed in-house. Nano Dimension Ltd. was incorporated in 1960 and is headquartered in Ness Ziona, Israel.
NASDAQ ended the session with Nano Dimension falling 1.06% to $2.33 on Thursday, after two sequential sessions in a row of losses. NASDAQ slid 1.21% to $13,502.20, after three successive sessions in a row of losses, on what was an all-around negative trend trading session today.
Earnings Per Share
As for profitability, Nano Dimension has a trailing twelve months EPS of $-0.91.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -18.3%.
Moving Average
Nano Dimension’s value is way under its 50-day moving average of $2.61 and way under its 200-day moving average of $2.65.
More news about Nano Dimension.
4. CSX Corporation (CSX) – Premarket: 0.72%
CSX Corporation, together with its subsidiaries, provides rail-based freight transportation services. The company offers rail services; and transportation of intermodal containers and trailers, as well as other transportation services, such as rail-to-truck transfers and bulk commodity operations. It transports chemicals, agricultural and food products, minerals, automotive, forest products, fertilizers, and metals and equipment; and coal, coke, and iron ore to electricity-generating power plants, steel manufacturers, and industrial plants, as well as exports coal to deep-water port facilities. The company also offers intermodal transportation services through a network of approximately 30 terminals transporting manufactured consumer goods in containers; and drayage services, including the pickup and delivery of intermodal shipments. It serves the automotive industry with distribution centers and storage locations, as well as connects non-rail served customers through transferring products, such as plastics and ethanol from rail to trucks. The company operates approximately 20,000 route mile rail network, which serves various population centers in 26 states east of the Mississippi River, the District of Columbia, and the Canadian provinces of Ontario and Quebec, as well as owns and leases approximately 3,600 locomotives. It also serves production and distribution facilities through track connections. CSX Corporation was incorporated in 1978 and is headquartered in Jacksonville, Florida.
NASDAQ ended the session with CSX Corporation rising 0.68% to $33.13 on Thursday, following the last session’s upward trend. NASDAQ dropped 1.21% to $13,502.20, after three consecutive sessions in a row of losses, on what was an all-around negative trend trading session today.
Earnings Per Share
As for profitability, CSX Corporation has a trailing twelve months EPS of $2.04.
PE Ratio
CSX Corporation has a trailing twelve months price to earnings ratio of 16.24. Meaning, the purchaser of the share is investing $16.24 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 33.64%.
More news about CSX Corporation.
5. Southwestern Energy (SWN) – Premarket: 0.36%
Southwestern Energy Company, an independent energy company, engages in the exploration, development, and production of natural gas, oil, and natural gas liquids (NGLs) in the United States. It operates through two segments, Exploration and Production, and Marketing. The company focuses on the development of unconventional natural gas and oil reservoirs located in Pennsylvania, West Virginia, Ohio, and Louisiana. It also engages in the marketing and transportation of natural gas, oil, and NGLs. The company serves LNG exporters, energy companies, utilities, and industrial purchasers of natural gas. Southwestern Energy Company was incorporated in 1929 and is headquartered in Spring, Texas.
NYSE ended the session with Southwestern Energy jumping 0.83% to $5.49 on Thursday while NYSE rose 0.05% to $15,657.00.
Earnings Per Share
As for profitability, Southwestern Energy has a trailing twelve months EPS of $5.7.
PE Ratio
Southwestern Energy has a trailing twelve months price to earnings ratio of 0.96. Meaning, the purchaser of the share is investing $0.96 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 210.69%.
Yearly Top and Bottom Value
Southwestern Energy’s stock is valued at $5.49 at 08:34 EST, way under its 52-week high of $8.39 and way above its 52-week low of $4.57.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is a negative 69.7% and a negative 62.5%, respectively.
More news about Southwestern Energy.
6. Vanguard Total International Bond (BNDX) – Premarket: 0.18%
NASDAQ ended the session with Vanguard Total International Bond rising 0.01% to $48.77 on Thursday, after four consecutive sessions in a row of gains. NASDAQ fell 1.21% to $13,502.20, after three successive sessions in a row of losses, on what was an all-around negative trend trading session today.
Earnings Per Share
As for profitability, Vanguard Total International Bond has a trailing twelve months EPS of $1.69.
Volatility
Vanguard Total International Bond’s last week, last month’s, and last quarter’s current intraday variation average was 0.12%, 0.02%, and 0.24%.
Vanguard Total International Bond’s highest amplitude of average volatility was 0.12% (last week), 0.23% (last month), and 0.24% (last quarter).
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Vanguard Total International Bond’s stock is considered to be oversold (<=20).
Volume
Today’s last reported volume for Vanguard Total International Bond is 1771710 which is 19.47% below its average volume of 2200160.
More news about Vanguard Total International Bond.
7. NRG Energy (NRG) – Premarket: 0.06%
NRG Energy, Inc., together with its subsidiaries, operates as an integrated power company in the United States. It operates through Texas, East, and West segments. The company is involved in producing and selling electricity and related products and services to approximately residential, commercial, industrial, and wholesale customers. It generates electricity using natural gas, coal, oil, solar, nuclear, and battery storage. The company also provides system power, distributed generation, renewable products, backup generation, storage and distributed solar, demand response, and energy efficiency and advisory services, as well as carbon management and specialty services. In addition, it trades in electric power, natural gas, and related commodities; environmental products; weather products; and financial products, including forwards, futures, options, and swaps. Further, the company procures fuels; and sells energy, services, and products and services under the NRG, Reliant, Direct Energy, Green Mountain Energy, Stream, and XOOM Energy. NRG Energy, Inc. was founded in 1989 and is headquartered in Houston, Texas.
NYSE ended the session with NRG Energy rising 1.09% to $33.88 on Thursday while NYSE rose 0.05% to $15,657.00.
Earnings Per Share
As for profitability, NRG Energy has a trailing twelve months EPS of $-7.82.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -45.62%.
More news about NRG Energy.
8. Coca-Cola (KO) – Premarket: 0%
The Coca-Cola Company, a beverage company, manufactures, markets, and sells various nonalcoholic beverages worldwide. The company provides sparkling soft drinks, sparkling flavors; water, sports, coffee, and tea; juice, value-added dairy, and plant-based beverages; and other beverages. It also offers beverage concentrates and syrups, as well as fountain syrups to fountain retailers, such as restaurants and convenience stores. The company sells its products under the Coca-Cola, Diet Coke/Coca-Cola Light, Coca-Cola Zero Sugar, Diet Coke, Cherry Coke, Fanta Orange, Fanta Zero Orange, Fanta Zero Sugar, Fanta Apple, Sprite, Sprite Zero Sugar, Simply Orange, Simply Apple, Simply Grapefruit, Fresca, Schweppes, Thums Up, Aquarius, Ayataka, BODYARMOR, Ciel, Costa, Dasani, dogadan, FUZE TEA, Georgia, glacéau smartwater, glacéau vitaminwater, Gold Peak, Ice Dew, I LOHAS, Powerade, Topo Chico, AdeS, Del Valle, fairlife, innocent, Minute Maid, and Minute Maid Pulpy brands. It operates through a network of independent bottling partners, distributors, wholesalers, and retailers, as well as through bottling and distribution operators. The company was founded in 1886 and is headquartered in Atlanta, Georgia.
NYSE ended the session with Coca-Cola jumping 0.28% to $61.43 on Thursday while NYSE rose 0.05% to $15,657.00.
Earnings Per Share
As for profitability, Coca-Cola has a trailing twelve months EPS of $2.27.
PE Ratio
Coca-Cola has a trailing twelve months price to earnings ratio of 27.06. Meaning, the purchaser of the share is investing $27.06 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 36.83%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Coca-Cola’s EBITDA is 6.78.
Sales Growth
Coca-Cola’s sales growth is 3.5% for the ongoing quarter and 10.4% for the next.
Volume
Today’s last reported volume for Coca-Cola is 4986590 which is 61.38% below its average volume of 12914300.
More news about Coca-Cola.
9. SK Telecom (SKM) – Premarket: 0%
SK Telecom Co., Ltd. provides wireless telecommunication services in South Korea. The company operates through three segments: Cellular Services, Fixed-Line Telecommunications Services, and Other Businesses. The Cellular Services segment offers wireless voice and data transmission, Internet of Things solutions, platform, cloud, smart factory solutions, subscription, advertising and curated shopping under T Deal brand name, and metaverse platform-based services, as well as sells wireless devices. The Fixed-Line Telecommunications Services segment provides fixed-line telephone services; broadband Internet services; media platform services, such as Internet protocol TV and cable TV; and business communications services. The Other Businesses segment offers T-commerce services, as well as portal services under Nate brand name. In addition, it provides call center management, base station maintenance, information gathering and consulting, database and internet website, cable broadcasting, broadcasting programs, and digital contents sourcing services; manufactures non-memory and other electronic integrated circuits; and operates information and communications facilities, and mobile virtual network, as well as engages in communications and other telecommunication device retail business. The company was incorporated in 1984 and is headquartered in Seoul, South Korea.
NYSE ended the session with SK Telecom dropping 0.02% to $20.08 on Thursday while NYSE jumped 0.05% to $15,657.00.
Earnings Per Share
As for profitability, SK Telecom has a trailing twelve months EPS of $1.95.
PE Ratio
SK Telecom has a trailing twelve months price to earnings ratio of 10.3. Meaning, the purchaser of the share is investing $10.3 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.74%.
Volatility
SK Telecom’s last week, last month’s, and last quarter’s current intraday variation average was a negative 2.83%, a negative 0.19%, and a positive 0.85%.
SK Telecom’s highest amplitude of average volatility was 2.83% (last week), 0.73% (last month), and 0.85% (last quarter).
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, SK Telecom’s stock is considered to be overbought (>=80).
Earnings Before Interest, Taxes, Depreciation, and Amortization
SK Telecom’s EBITDA is 0.01.
More news about SK Telecom.
10. Smith & Wesson (SWBI) – Premarket: 0%
Smith & Wesson Brands, Inc. designs, manufactures, and sells firearms worldwide. The company offers handguns, including revolvers and pistols; long guns, such as modern sporting rifles, bolt action rifles; handcuffs; suppressors; and other firearm-related products under the Smith & Wesson, M&P, and Gemtech brands. It also provides manufacturing services comprising forging, heat treating, rapid prototyping, tooling, finishing, plating, machining, and custom plastic injection molding to other businesses under the Smith & Wesson and Smith & Wesson Precision Components brand names; and sells parts purchased through third parties. The company sells its products to firearm enthusiasts, collectors, hunters, sportsmen, competitive shooters, individuals desiring home and personal protection, law enforcement, security agencies and officers, and military agencies. It markets its products through independent dealers, retailers, in-store retails, and direct to consumers; print, broadcast, and digital advertising campaigns; social and electronic media; and in-store retail merchandising strategies. Smith & Wesson Brands, Inc. was founded in 1852 and is based in Springfield, Massachusetts.
NASDAQ ended the session with Smith & Wesson rising 0.52% to $11.70 on Thursday, following the last session’s upward trend. NASDAQ slid 1.21% to $13,502.20, after three consecutive sessions in a row of losses, on what was an all-around negative trend trading session today.
Earnings Per Share
As for profitability, Smith & Wesson has a trailing twelve months EPS of $1.32.
PE Ratio
Smith & Wesson has a trailing twelve months price to earnings ratio of 8.86. Meaning, the purchaser of the share is investing $8.86 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.18%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Smith & Wesson’s EBITDA is 33.75.
Revenue Growth
Year-on-year quarterly revenue growth declined by 27.4%, now sitting on 515.76M for the twelve trailing months.
More news about Smith & Wesson.
Premarket Losers Today
1. Gyrodyne (GYRO) – Premarket: -5.9%
Gyrodyne, LLC owns and manages a diversified portfolio of real estate properties comprising office, industrial and service-oriented properties in the New York metropolitan area. Gyrodyne owns a 63 acre site approximately 50 miles east of New York City on the north shore of Long Island, which includes industrial and office buildings and undeveloped property which is the subject of plans to seek value-enhancing entitlements. Gyrodyne also owns a medical office park in Cortlandt Manor, New York which is also the subject of a subdivision application. Gyrodyne's common shares are traded on the NASDAQ Stock Market under the symbol GYRO.
NASDAQ ended the session with Gyrodyne jumping 0.08% to $11.70 on Thursday, following the last session’s downward trend. NASDAQ dropped 1.21% to $13,502.20, after three consecutive sessions in a row of losses, on what was an all-around bearish trend exchanging session today.
Earnings Per Share
As for profitability, Gyrodyne has a trailing twelve months EPS of $0.18.
PE Ratio
Gyrodyne has a trailing twelve months price to earnings ratio of 65. Meaning, the purchaser of the share is investing $65 for every dollar of annual earnings.
Revenue Growth
Year-on-year quarterly revenue growth declined by 1.8%, now sitting on 2.74M for the twelve trailing months.
Volatility
Gyrodyne’s last week, last month’s, and last quarter’s current intraday variation average was 20.00%, 4.42%, and 4.08%.
Gyrodyne’s highest amplitude of average volatility was 20.00% (last week), 5.15% (last month), and 4.08% (last quarter).
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Gyrodyne’s stock is considered to be oversold (<=20).
Volume
Today’s last reported volume for Gyrodyne is 746 which is 50.56% below its average volume of 1509.
More news about Gyrodyne.
2. Inovio Pharmaceuticals (INO) – Premarket: -2.25%
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA sequence of the target antigen, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids. The company engages in conducting and planning clinical studies of its DNA medicines for HPV-associated precancers. Its products in pipeline include VGX-3100 for the treatment of HPV-related cervical high-grade dysplasia, including cervical, vulvar, and anal dysplasia and is under phase II/III clinical trials; INO-3107 for HPV-related recurrent respiratory rapillomatosis and is under Phase 1/2 trial; INO-5401 for the treatment of glioblastoma multiforme and is under Phase 2 trial; INO-4201 for Ebola Virus Disease and is under phase 1b trial; and INO-4500 vaccine for lassa fever, which is under phase 1b trial. Its partners and collaborators include Advaccine Biopharmaceuticals Suzhou Co, ApolloBio Corporation, AstraZeneca, The Bill & Melinda Gates Foundation, Coalition for Epidemic Preparedness Innovations, Defense Advanced Research Projects Agency, The U.S. Department of Defense, HIV Vaccines Trial Network, International Vaccine Institute, Kaneka Eurogentec, National Cancer Institute, National Institutes of Health, National Institute of Allergy and Infectious Diseases, the Parker Institute for Cancer Immunotherapy, Plumbline Life Sciences, Regeneron Pharmaceuticals, Richter-Helm BioLogics, Thermo Fisher Scientific, the University of Pennsylvania, the Walter Reed Army Institute of Research, and The Wistar Institute. The company was incorporated in 1983 and is headquartered in Plymouth Meeting, Pennsylvania.
NASDAQ ended the session with Inovio Pharmaceuticals sliding 3.02% to $0.48 on Thursday while NASDAQ slid 1.21% to $13,502.20.
Earnings Per Share
As for profitability, Inovio Pharmaceuticals has a trailing twelve months EPS of $-0.94.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -87.1%.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 69.6% and 13.3%, respectively.
Volume
Today’s last reported volume for Inovio Pharmaceuticals is 6510570 which is 25.37% below its average volume of 8724070.
More news about Inovio Pharmaceuticals.
3. GlaxoSmithKline (GSK) – Premarket: -1.59%
GSK plc, together with its subsidiaries, engages in the research, development and manufacture of vaccines and specialty medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as infectious disease, HIV, immunology and respiratory, and oncology. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is based in Brentford, the United Kingdom.
NYSE ended the session with GlaxoSmithKline jumping 1.53% to $35.15 on Thursday while NYSE jumped 0.05% to $15,657.00.
Earnings Per Share
As for profitability, GlaxoSmithKline has a trailing twelve months EPS of $2.76.
PE Ratio
GlaxoSmithKline has a trailing twelve months price to earnings ratio of 12.74. Meaning, the purchaser of the share is investing $12.74 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 28.17%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, GlaxoSmithKline’s stock is considered to be overbought (>=80).
More news about GlaxoSmithKline.
4. Smith & Nephew (SNN) – Premarket: -0.7%
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. The company operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products, including instruments, technologies, and implants to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
NYSE ended the session with Smith & Nephew sliding 1.15% to $31.33 on Thursday, after four consecutive sessions in a row of losses. NYSE rose 0.05% to $15,657.00, following the last session’s upward trend on what was a somewhat positive trend exchanging session today.
Earnings Per Share
As for profitability, Smith & Nephew has a trailing twelve months EPS of $0.51.
PE Ratio
Smith & Nephew has a trailing twelve months price to earnings ratio of 61.42. Meaning, the purchaser of the share is investing $61.42 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.12%.
Yearly Top and Bottom Value
Smith & Nephew’s stock is valued at $31.33 at 08:34 EST, below its 52-week high of $33.09 and way higher than its 52-week low of $21.78.
Volume
Today’s last reported volume for Smith & Nephew is 326105 which is 65.28% below its average volume of 939482.
Volatility
Smith & Nephew’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.49%, a negative 0.01%, and a positive 1.00%.
Smith & Nephew’s highest amplitude of average volatility was 0.99% (last week), 1.08% (last month), and 1.00% (last quarter).
Moving Average
Smith & Nephew’s value is above its 50-day moving average of $29.82 and way above its 200-day moving average of $26.89.
More news about Smith & Nephew.
5. Fresenius Medical Care AG (FMS) – Premarket: -0.42%
Fresenius Medical Care AG & Co. KGaA provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. It also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.
NYSE ended the session with Fresenius Medical Care AG rising 0.83% to $23.65 on Thursday, after two consecutive sessions in a row of gains. NYSE jumped 0.05% to $15,657.00, following the last session’s upward trend on what was a somewhat bullish trend exchanging session today.
Earnings Per Share
As for profitability, Fresenius Medical Care AG has a trailing twelve months EPS of $1.11.
PE Ratio
Fresenius Medical Care AG has a trailing twelve months price to earnings ratio of 21.3. Meaning, the purchaser of the share is investing $21.3 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.49%.
Volatility
Fresenius Medical Care AG’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.06%, a positive 0.10%, and a positive 1.47%.
Fresenius Medical Care AG’s highest amplitude of average volatility was 0.62% (last week), 1.18% (last month), and 1.47% (last quarter).
Moving Average
Fresenius Medical Care AG’s worth is higher than its 50-day moving average of $22.69 and way above its 200-day moving average of $18.25.
More news about Fresenius Medical Care AG.
6. Petroleo Brasileiro (PBR) – Premarket: -0.13%
Petróleo Brasileiro S.A. – Petrobras explores, produces, and sells oil and gas in Brazil and internationally. The company operates through Exploration and Production; Refining, Transportation and Marketing; and Gas and Power. It also engages in prospecting, drilling, refining, processing, trading, and transporting crude oil from producing onshore and offshore oil fields, and shale or other rocks, as well as oil products, natural gas, and other liquid hydrocarbons. The Exploration and Production segment explores, develops, and produces crude oil, natural gas liquids, and natural gas primarily for supplies to the domestic refineries. The Refining, Transportation and Marketing segment engages in the refining, logistics, transport, marketing, and trading of crude oil and oil products; exportation of ethanol; and extraction and processing of shale, as well as holding interests in petrochemical companies. The Gas and Power segment is involved in the logistic and trading of natural gas and electricity; transportation and trading of LNG; generation of electricity through thermoelectric power plants; holding interests in transportation and distribution of natural gas; and fertilizer production and natural gas processing business. In addition, the company produces biodiesel and its co-products, and ethanol; and distributes oil products. Further, it engages in research, development, production, transport, distribution, and trading of energy. Petróleo Brasileiro S.A. – Petrobras was incorporated in 1953 and is headquartered in Rio de Janeiro, Brazil.
NYSE ended the session with Petroleo Brasileiro rising 4.98% to $14.94 on Thursday while NYSE jumped 0.05% to $15,657.00.
Earnings Per Share
As for profitability, Petroleo Brasileiro has a trailing twelve months EPS of $5.42.
PE Ratio
Petroleo Brasileiro has a trailing twelve months price to earnings ratio of 2.76. Meaning, the purchaser of the share is investing $2.76 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 43.44%.
More news about Petroleo Brasileiro.
7. Ares Capital (ARCC) – Premarket: -0.05%
Ares Capital Corporation is a business development company specializing in acquisition, recapitalization, mezzanine debt, restructurings, rescue financing, and leveraged buyout transactions of middle market companies. It also makes growth capital and general refinancing. It prefers to make investments in companies engaged in the basic and growth manufacturing, business services, consumer products, health care products and services, and information technology service sectors. The fund will also consider investments in industries such as restaurants, retail, oil and gas, and technology sectors. It focuses on investments in Northeast, Mid-Atlantic, Southeast and Southwest regions from its New York office, the Midwest region, from the Chicago office, and the Western region from the Los Angeles office. The fund typically invests between $20 million and $200 million and a maximum of $400 million in companies with an EBITDA between $10 million and $250 million. It makes debt investments between $10 million and $100 million The fund invests through revolvers, first lien loans, warrants, unitranche structures, second lien loans, mezzanine debt, private high yield, junior capital, subordinated debt, and non-control preferred and common equity. The fund also selectively considers third-party-led senior and subordinated debt financings and opportunistically considers the purchase of stressed and discounted debt positions. The fund prefers to be an agent and/or lead the transactions in which it invests. The fund also seeks board representation in its portfolio companies.
NASDAQ ended the session with Ares Capital jumping 0.27% to $18.59 on Thursday, after two consecutive sessions in a row of gains. NASDAQ fell 1.21% to $13,502.20, after three sequential sessions in a row of losses, on what was an all-around down trend trading session today.
Earnings Per Share
As for profitability, Ares Capital has a trailing twelve months EPS of $1.27.
PE Ratio
Ares Capital has a trailing twelve months price to earnings ratio of 14.64. Meaning, the purchaser of the share is investing $14.64 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.87%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Ares Capital’s EBITDA is 15.23.
Revenue Growth
Year-on-year quarterly revenue growth grew by 40.5%, now sitting on 2.27B for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Ares Capital’s stock is considered to be overbought (>=80).
More news about Ares Capital.
8. Wipro Limited (WIT) – Premarket: 0%
Wipro Limited operates as an information technology (IT), consulting, and business process services company worldwide. It operates through three segments: IT Services, IT Products, and India State Run Enterprise Services (ISRE). The IT Services segment offers IT and IT-enabled services, including digital strategy advisory, customer-centric design, technology and IT consulting, custom application design, development, re-engineering and maintenance, systems integration, package implementation, cloud and infrastructure, business process, cloud, mobility and analytics, research and development, and hardware and software design services to enterprises. It serves customers in various industry sectors, such as healthcare and medical devices, consumer goods and life sciences, retail, transportation and services, communications, media and information services, technology products and platforms, banking, financial services and insurance, manufacturing, hi-tech, energy, and utilities. The IT Products segment provides a range of third-party IT products comprising enterprise platforms, networking solutions, software and data storage products, contact center infrastructure, enterprise security, IT optimization technologies, video solutions, and end-user computing solutions. It serves enterprises in various industries primarily in the Indian market, which comprise the government, defense, IT and IT-enabled services, telecommunications, manufacturing, utilities, education, and financial services sectors. The ISRE segment offers IT services to entities and departments owned or controlled by the Government of India and/or various Indian State Governments. It also provides cybersecurity consulting services. The company was incorporated in 1945 and is based in Bengaluru, India.
NYSE ended the session with Wipro Limited falling 0.32% to $4.62 on Thursday, after five sequential sessions in a row of losses. NYSE rose 0.05% to $15,657.00, following the last session’s upward trend on what was a somewhat positive trend trading session today.
Earnings Per Share
As for profitability, Wipro Limited has a trailing twelve months EPS of $0.25.
PE Ratio
Wipro Limited has a trailing twelve months price to earnings ratio of 18.46. Meaning, the purchaser of the share is investing $18.46 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.78%.
More news about Wipro Limited.
9. Smith & Wesson (SWBI) – Premarket: 0%
Smith & Wesson Brands, Inc. designs, manufactures, and sells firearms worldwide. The company offers handguns, including revolvers and pistols; long guns, such as modern sporting rifles, bolt action rifles; handcuffs; suppressors; and other firearm-related products under the Smith & Wesson, M&P, and Gemtech brands. It also provides manufacturing services comprising forging, heat treating, rapid prototyping, tooling, finishing, plating, machining, and custom plastic injection molding to other businesses under the Smith & Wesson and Smith & Wesson Precision Components brand names; and sells parts purchased through third parties. The company sells its products to firearm enthusiasts, collectors, hunters, sportsmen, competitive shooters, individuals desiring home and personal protection, law enforcement, security agencies and officers, and military agencies. It markets its products through independent dealers, retailers, in-store retails, and direct to consumers; print, broadcast, and digital advertising campaigns; social and electronic media; and in-store retail merchandising strategies. Smith & Wesson Brands, Inc. was founded in 1852 and is based in Springfield, Massachusetts.
NASDAQ ended the session with Smith & Wesson rising 0.52% to $11.70 on Thursday, following the last session’s upward trend. NASDAQ dropped 1.21% to $13,502.20, after three sequential sessions in a row of losses, on what was an all-around bearish trend trading session today.
Earnings Per Share
As for profitability, Smith & Wesson has a trailing twelve months EPS of $1.32.
PE Ratio
Smith & Wesson has a trailing twelve months price to earnings ratio of 8.86. Meaning, the purchaser of the share is investing $8.86 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.18%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 27.4%, now sitting on 515.76M for the twelve trailing months.
Volume
Today’s last reported volume for Smith & Wesson is 365196 which is 5.6% below its average volume of 386890.
Moving Average
Smith & Wesson’s value is below its 50-day moving average of $12.11 and higher than its 200-day moving average of $11.17.
More news about Smith & Wesson.
10. Coca-Cola (KO) – Premarket: 0%
The Coca-Cola Company, a beverage company, manufactures, markets, and sells various nonalcoholic beverages worldwide. The company provides sparkling soft drinks, sparkling flavors; water, sports, coffee, and tea; juice, value-added dairy, and plant-based beverages; and other beverages. It also offers beverage concentrates and syrups, as well as fountain syrups to fountain retailers, such as restaurants and convenience stores. The company sells its products under the Coca-Cola, Diet Coke/Coca-Cola Light, Coca-Cola Zero Sugar, Diet Coke, Cherry Coke, Fanta Orange, Fanta Zero Orange, Fanta Zero Sugar, Fanta Apple, Sprite, Sprite Zero Sugar, Simply Orange, Simply Apple, Simply Grapefruit, Fresca, Schweppes, Thums Up, Aquarius, Ayataka, BODYARMOR, Ciel, Costa, Dasani, dogadan, FUZE TEA, Georgia, glacéau smartwater, glacéau vitaminwater, Gold Peak, Ice Dew, I LOHAS, Powerade, Topo Chico, AdeS, Del Valle, fairlife, innocent, Minute Maid, and Minute Maid Pulpy brands. It operates through a network of independent bottling partners, distributors, wholesalers, and retailers, as well as through bottling and distribution operators. The company was founded in 1886 and is headquartered in Atlanta, Georgia.
NYSE ended the session with Coca-Cola rising 0.28% to $61.43 on Thursday while NYSE jumped 0.05% to $15,657.00.
Earnings Per Share
As for profitability, Coca-Cola has a trailing twelve months EPS of $2.27.
PE Ratio
Coca-Cola has a trailing twelve months price to earnings ratio of 27.06. Meaning, the purchaser of the share is investing $27.06 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 36.83%.
More news about Coca-Cola.
Stay up to date with our premarket winners and losers daily report
